FibroBiologics, Inc.

FBLG

Form 4 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0001493152-26-008933
Filing date: Mar 5, 2026
Earliest execution date: Mar 4, 2026
Reporting Owners: Khoja Hamid (Chief Scientific Officer)
SEC Filing link

Summary

Type

Buy

Net shares

+30,000

% of shares

96.00%

Amount (USD)

$11,400

Insider confidence score

91.3 out of 100

Positive

  • Massive buy (≥10% of shares)

Negative

  • Small buy amount (<$50K)

Stock transactions

Transaction 1

Security

Common Stock

Action

Buy

Date

2026-03-04

Code

P

Net shares

+30,000.0

Price per Share

$0.38

Amount (USD)

$11,400.00

Acquired/Disposed

Acquired

Shares Owned Before

31,250.0

Shares Owned After

61,250.0

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.